Heidelberg, Germany

Christian Niesporek

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Roche Diabetes Care, Inc., Roche Diagnostics Gmbh, Roche Diagnostics Operations, Inc.. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Niesporek. Retrieved from https://idiyas.com/inventor/christian-niesporek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Christian Niesporek

Introduction

Christian Niesporek, based in Heidelberg, Germany, is a prominent inventor recognized for his contributions to medical analytics and diagnostics. With a total of two patents, Niesporek has focused his expertise on developing advanced methods and devices for determining analyte concentrations in body fluid samples. His work has significantly impacted the fields of diabetes care and infection diagnostics.

Latest Patents

Niesporek's most recent patents include innovative methods and analytical devices aimed at determining the concentration of analytes in body fluid samples. The first patent outlines a process for accurately assessing an analyte concentration by applying a body fluid to a test carrier, illuminating it with multiple modulation frequencies, and employing detectors to evaluate signals generated during the analysis. This technique includes fault detection by comparing demodulated signals, enhancing the reliability of the results.

The second patent describes a modular blood glucose test instrument kit. This kit is designed with interchangeable components that allow for the assembly of various handheld blood glucose testing devices. It consists of an interconnection platform, multiple measurement engine modules, user interface modules, and power supply modules. This modular system not only enhances the versatility of glucose testing but also promotes reliability through established communication protocols among the different modules.

Career Highlights

Throughout his career, Christian Niesporek has held significant positions in leading companies such as Roche Diabetes Care and Roche Diagnostics Operations. His work in these organizations has been pivotal in driving forward innovative solutions for diabetes management, contributing to improved health outcomes for patients around the world.

Collaborations

Niesporek has worked closely with various esteemed colleagues, including Kai-Oliver Schwenker and Gertrud Albrecht. These collaborations have facilitated the exchange of ideas and fostered advancements in the technologies related to medical diagnostics and analyte measurement.

Conclusion

Christian Niesporek’s inventive contributions continue to play a crucial role in the evolution of medical testing technologies. With patents focused on analyte concentration determination and modular diagnostic devices, he is helping to shape a future where medical diagnostics is more efficient and accessible. His work underscores the importance of innovation in healthcare, making significant strides toward better diabetes management and overall patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…